Zealand Pharma A/S (ZEAL) — Tangible Net Worth Ratio
Zealand Pharma A/S (ZEAL) has a Tangible Net Worth Ratio of 99.7% as of December 2025. This metric is calculated by deducting intangible assets (Dkr44.97 Million) from net assets (Dkr14.83 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Zealand Pharma A/S current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zealand Pharma A/S Tangible Net Worth Ratio (2007–2025)
This chart shows how Zealand Pharma A/S's Tangible Net Worth Ratio has changed across 19 annual periods from 2007 to 2025. As of December 2025, the ratio stands at 99.7%, reflecting net assets of Dkr14.83 Billion with intangible assets of Dkr44.97 Million DKK. See Zealand Pharma A/S defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Zealand Pharma A/S (2007–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zealand Pharma A/S from 2007 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see ZEAL stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (DKK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | Dkr14.83 Billion | Dkr44.97 Million | Dkr16.46 Billion | ▼ -0.2 pp |
| 2024 | 99.9% | Dkr8.62 Billion | Dkr12.62 Million | Dkr9.51 Billion | ▲ +0.6 pp |
| 2023 | 99.2% | Dkr1.59 Billion | Dkr12.26 Million | Dkr1.98 Billion | ▼ -0.8 pp |
| 2022 | 100.0% | Dkr815.91 Million | Dkr0.00 | Dkr1.54 Billion | ▲ +5.8 pp |
| 2021 | 94.2% | Dkr927.80 Million | Dkr53.79 Million | Dkr2.07 Billion | ▼ -0.9 pp |
| 2020 | 95.1% | Dkr1.18 Billion | Dkr57.48 Million | Dkr1.92 Billion | ▼ -4.7 pp |
| 2019 | 99.8% | Dkr1.24 Billion | Dkr2.48 Million | Dkr1.60 Billion | ▼ -0.2 pp |
| 2018 | 100.0% | Dkr1.12 Billion | Dkr0.00 | Dkr1.23 Billion | ▲ +0.0 pp |
| 2017 | 100.0% | Dkr528.47 Million | Dkr0.00 | Dkr737.24 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Dkr278.19 Million | Dkr0.00 | Dkr694.63 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Dkr252.23 Million | Dkr0.00 | Dkr634.69 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Dkr252.83 Million | Dkr0.00 | Dkr596.76 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Dkr316.14 Million | Dkr0.00 | Dkr346.91 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Dkr491.01 Million | Dkr0.00 | Dkr522.40 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Dkr441.40 Million | Dkr0.00 | Dkr469.48 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Dkr407.11 Million | Dkr0.00 | Dkr450.55 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Dkr132.92 Million | Dkr0.00 | Dkr158.68 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Dkr208.63 Million | Dkr0.00 | Dkr225.24 Million | ▲ +0.0 pp |
| 2007 | 100.0% | Dkr242.37 Million | Dkr0.00 | Dkr263.37 Million | — |